Search Results - "Mohebtash, Mahsa"

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial by Madan, Ravi A, MD, Mohebtash, Mahsa, MD, Arlen, Philip M, MD, Vergati, Matteo, MD, Rauckhorst, Myrna, RN, Steinberg, Seth M, PhD, Tsang, Kwong Y, PhD, Poole, Diane J, Parnes, Howard L, MD, Wright, John J, MD PhD, Dahut, William L, MD, Schlom, Jeffrey, PhD, Gulley, James L, Dr

“…Summary Background Therapeutic cancer vaccines have shown activity in metastatic castration-resistant prostate cancer (mCRPC), and methods are being assessed…”
Get full text

A rare case of bilateral breast lobular carcinoma coexisting with primary breast follicular lymphoma by Mirkheshti, Nooshin, Mohebtash, Mahsa

“…CLINICAL PRACTICE POINTS ● Co-existence of breast cancer and lymphoma is a rare condition. A few cases of synchronous breast ductal carcinoma and lymphoma have…”
Get full text

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer by Lynce, Filipa, Saleh, Mervat, Shajahan-Haq, Ayesha, Gallagher, Christopher, Dilawari, Asma, Hahn, Olwen, Abu-Khalaf, Maysa, Cai, Ling, Pohlmann, Paula, Mohebtash, Mahsa, Kamugisha, Lois, Isaacs, Claudine

“…Abstract Palbociclib has been shown to be a highly effective therapy in hormone receptor positive metastatic breast cancer when used in combination with…”
Get full text

Hemolytic uremic syndrome and Clostridium difficile colitis by Keshtkar-Jahromi, Maryam, Mohebtash, Mahsa

“…Hemolytic uremic syndrome (HUS) can be associated with different infectious etiologies, but the relationship between pseudomembranous colitis and HUS was first…”
Get full text

Promising novel immunotherapies and combinations for prostate cancer by Arlen, Philip M, Mohebtash, Mahsa, Madan, Ravi A, Gulley, James L

“…The field of therapeutic cancer vaccines is currently in a state of active preclinical and clinical investigation, and certain novel therapies involving tumor…”
Get more information

Implementation of a secure mobile application to improve care of patients with breast cancer: Experience from a medically underserved area by Adhikari, Biplov, Marasini, Anurag, Mohebtash, Mahsa, Farha, Maen Jamal

“…e18701 Background: Breast cancer care is complex and requires coordination of interdependent events and patient communication to reduce delays and missed…”
Get full text

Feasibility of Mass Screening for Colorectal Cancer Using Fecal Immunochemical Test in Iran by Kamangar, Farin, Mohebtash, Mahsa

Get full text

Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin by Jain, Varun, Mohebtash, Mahsa, Rodrigo, Maria E, Ruiz, George, Atkins, Michael B, Barac, Ana

“…The immune checkpoint inhibitors have brought about a paradigm shift in the treatment of many cancers and are being used as the first line therapy in…”
Get full text

Cardiovascular Complications Associated With Novel Cancer Immunotherapies by Jain, Varun, Bahia, Jaspreet, Mohebtash, Mahsa, Barac, Ana

“…Opinion statement Immune therapies represent a quantum leap in the fight against cancer. Recently approved immune checkpoint inhibitors that target receptors…”
Get full text

Literature on target therapy of malignant melanoma by Esmaeil Pour, Mohammad Ali, Mohebtash, Mahsa, Amin, Ali, Khayyat, Azadeh, Khalili-Toosi, Amir-Reza, Guo, Mengni, Mousavi, Seyedreza, Liu, Jieying

“…e21506 Background: Malignant melanoma (MM) of mucosal membranes (excluding anus and head and neck) is a rare but aggressive disease with poor outcome. There is…”
Get full text

Efficacy of the novel treatments of BCC with bone metastasis by Esmaeil Pour, Mohammad Ali, Mohebtash, Mahsa, Amin, Ali, Khayyat, Azadeh, Khalili-Toosi, Amir-Reza, Mousavi, Seyedreza, Guo, Mengni, Liu, Jieying

“…e14547 Background: Eighty percent of nonmelanoma skin malignancies are basal cell carcinomas (BCC). Metastasis in BCC is about 0.0028 to 0.55. Diagnosis and…”
Get full text

Severe Thrombocytopenia in Infective Endocarditis by Patel, Mayuri, Adhikari, Biplov, Devkota, Amrit, Mohebtash, Mahsa

“…Thrombocytopenia can be seen in about 20-25% of patients with bacterial infective endocarditis (IE). Platelets have a major role in the pathogenesis of…”
Get full text

HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane by Pohlmann, Paula R., Graham, Deena, Wu, Tianmin, Ottaviano, Yvonne, Mohebtash, Mahsa, Kurian, Shweta, McNamara, Donna, Lynce, Filipa, Warren, Robert, Dilawari, Asma, Rao, Suman, Mainor, Candace, Swanson, Nicole, Tan, Ming, Isaacs, Claudine, Swain, Sandra M.

“…Purpose To assess whether crofelemer would prevent chemotherapy-induced diarrhea (CID) diarrhea in patients with HER2-positive, any-stage breast cancer…”
Get full text

ODP527 To Treat or Not to Treat Pembrolizumab-Induced Thyroiditis: Using Common Terminology Criteria for Adverse Events as a Decision-Making Aid by Alatrash, Batool, Arnouk, Nelly, Cheikh, Malek, Mohebtash, Mahsa, Schroeder, Pamela

“…Abstract Introduction Programmed cell death-1 (PD-1) checkpoint inhibitors are immunotherapeutic agents that are used to treat advanced malignancies including…”
Get full text

Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer by Madan, Ravi A, Arlen, Philip M, Mohebtash, Mahsa, Hodge, James W, Gulley, James L

“…Prostvac is a prostate cancer vaccine regimen consisting of a recombinant vaccinia vector as a primary vaccination, followed by multiple booster vaccinations…”
Get more information

Abstract P5-18-09: Halt-d: A randomized open label phase 2 study of crofelemer for the prevention of chemotherapy induced diarrhea (cid) in patients with breast cancer receiving trastuzumab, pertuzumab, and a taxane by Pohlmann, Paula R, Graham, Deena, Wu, Tianmin, Ottaviano, Yvonne, Mohebtash, Mahsa, Kurian, Shweta, McNamara, Donna, Lynce, Filipa, Warren, Robert, Dilawari, Asma, Rao, Suman, Mainor, Candace, Swanson, Nicole, Tan, Ming, Isaacs, Claudine, Swain, Sandra M.

“…Abstract Background: CID occurs in up to 80% of patients with breast cancer who receive trastuzumab (H), pertuzumab (P), and a taxane, with grade 3 experienced…”
Get full text

Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer by Lynce, Filipa, Blackburn, Matthew J., Zhuo, Rebecca, Gallagher, Christopher, Hahn, Olwen M., Abu‐Khalaf, Maysa, Mohebtash, Mahsa, Wu, Tianmin, Pohlmann, Paula R., Dilawari, Asma, Tiwari, Shruti R., Chitalia, Ami, Warren, Robert, Tan, Ming, Shajahan‐Haq, Ayesha N., Isaacs, Claudine

“…Background Cyclin‐dependent kinase 4/6 (CDK4/6) inhibitors, including palbociclib, are approved to treat hormone receptor (HR)‐positive/human epidermal growth…”
Get full text

Immunotherapy: A Future Treatment Modality for Breast Cancer? by Mahsa Mohebtash, Farin Kamangar

Get full text

Abstract P1-19-20: Safety of palbociclib in African American women with hormone receptor positive HER2 negative advanced breast cancer and benign ethnic neutropenia: PALINA study by Lynce, Filipa, Zhuo, Rebecca, Blackburn, Matthew, Gallagher, Christopher, Hahn, Olwen, Abu-Khalaf, Maysa, Mohebtash, Mahsa, Wu, Tianmin, Pohlmann, Paula, Dilawari, Asma, Tiwari, Shruti, Chitalia, Ami, Warren, Robert, Tan, Ming, Shajahan-Haq, Ayesha, Isaacs, Claudine

“…Abstract Background: There are significant racial disparities in breast cancer outcomes between African American women (AAW) and Caucasian women (CW) in the…”
Get full text

Helicobacter pylori and its effects on human health and disease by Kamangar, Farin, Sheikhattari, Payam, Mohebtash, Mahsa

“…H. pylori is now a known cause of gastric and duodenal ulcers, noncardia gastric cancer and gastric MALT lymphoma. In addition, the role of this microorganism…”
Get full text